RMP-7: Began two Phase I/II trials

Alkermes Inc. (ALKS), Cambridge, Mass. Product: RMP-7 permeability enhancer for the blood-brain barrier Indication: Deliver carboplatin to patients with advanced-stage malignant glioma Status: Began t...